News from royalty pharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Toronto:AMB)

May 06, 2014, 07:00 ET

Avillion Announces Royalty Pharma Investment

Avillion LLP, a company focused on co-development and financing of late-stage pharmaceutical candidates from Phase 3 clinical development through...

Jan 06, 2014, 08:00 ET
Royalty Pharma.  (PRNewsFoto/Royalty Pharma)

Royalty Pharma Acquires Additional Interest in TECFIDERA® for $510 Million

 Royalty Pharma announced today that it has acquired an additional interest in the earn-out payable to the former shareholders of Fumapharm AG...

Aug 12, 2013, 07:00 ET
Royalty Pharma.  (PRNewsFoto/Royalty Pharma)

Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase

 Royalty Pharma announced today that, pursuant to a collaboration with Aisling Capital and Clarus Ventures, it has...

Jul 19, 2013, 08:00 ET

Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team

 Royalty Pharma is pleased to announce that Marshall Urist, MD, PhD, has joined the company as Vice President, Research and Investments. ...

Jul 18, 2013, 06:30 ET
Quest Diagnostics Incorporated logo.  (PRNewsFoto/Quest Diagnostics Incorporated)

Quest Diagnostics Sells Ibrutinib Royalty Rights To Royalty Pharma For $485 Million In Cash

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed...

Jun 18, 2013, 06:43 ET

Royalty Pharma Announces Withdrawal Of Judicial Review And Lapse Of Offer

 Royalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel's decision requiring it to...

Jun 17, 2013, 10:31 ET

Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today

 As the Share Repurchase Resolution has been passed at the Elan EGM earlier today, Royalty Pharma's Offer for Elan Corporation, plc (NYSE: ELN)...

Jun 17, 2013, 02:26 ET

Royalty Pharma Chairman Writes Open Letter to Elan Board

 Royalty Pharma announced today that Rory Riggs, Chairman and Co-Founder of the Royalty Pharma group, is sending the following open letter to...

Jun 14, 2013, 13:34 ET

Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty

 Royalty Pharma notes today's announcement by Elan Corporation, plc (NYSE: ELN) that it intends to explore a sale of the Company. Royalty...

Jun 14, 2013, 01:41 ET

Elan ADS Holders Decisively Vote Against Theravance And AOP Transactions

 Royalty Pharma today announces that as of 3:00 pm EDT on Thursday, June 13, 2013 holders of approximately 311 million Elan ADSs, representing...

Jun 13, 2013, 07:53 ET

Royalty Pharma Announces Offer May Lapse (Be Withdrawn)

 Royalty Pharma today announces that as of 5:30 pm EDT on Wednesday, June 12, 2013 holders of approximately 276 million Elan ADSs (NYSE: ELN),...

Jun 11, 2013, 14:25 ET

Royalty Pharma Files Judicial Review Proceedings

 Royalty Pharma today announces that it has reluctantly filed judicial review proceedings related to the decision of the Irish Takeover Panel...

Jun 11, 2013, 11:24 ET

In Royalty Pharma's View, Elan's EGM Circular is Misleading and Omits Key Information that Elan Shareholders Need to Make an Informed Decision

 Royalty Pharma today announced that it believes Elan's (NYSE: ELN) disclosure in its May 27 EGM Circular is misleading and inadequate,...

Jun 11, 2013, 08:55 ET

Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit

 Royalty Pharma announced today that Elan voluntarily withdrew the lawsuit it had filed on an expedited basis only one week ago in New York...

Jun 11, 2013, 02:07 ET

Royalty Pharma Acceptances Announcement

 In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the US Exchange Act, Echo Pharma Acquisition Limited...

Jun 10, 2013, 18:46 ET

Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit

 Royalty Pharma announced today that Elan voluntarily withdrew the lawsuit it had filed on an expedited basis only one week ago in New York...

Jun 10, 2013, 17:18 ET

Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan

 Royalty Pharma today posted a new investor presentation summarizing its Further Increased Offer for Elan Corporation, plc (NYSE: ELN) and...

Jun 10, 2013, 06:33 ET

Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today

 Royalty Pharma today urged Elan Corporation, plc (NYSE: ELN) Shareholders to immediately vote AGAINST ALL FOUR resolutions Elan's Board has...

Jun 10, 2013, 02:04 ET

Royalty Pharma Posts Further Revised Offer Document In Offer For Elan Corporation, Plc ("Elan")

 Following its announcement on 7 June 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") has today issued a further revised offer...

Jun 07, 2013, 06:47 ET

Royalty Pharma Increases Offer to Acquire Elan to $13.00 Per Share in Cash Plus a Contingent Value Right of Up to $2.50 Per Share

 Royalty Pharma today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the "Announcement"), a firm intention to further increase...